Recently, the parylene-matrix chip was developed for quantitative analysis of small molecules less than 1 kDa. In this study, MALDI-TOF MS based on the parylene-matrix chip was performed to clinically diagnose intrahepatic cholangiocarcinoma (IHCC) and colorectal cancer (CRC). The parylene-matrix chip was applied for the detection of small cancer biomarkers, including N-methyl-2-pyridone-5-carboxamide (2PY), glutamine, lysophosphatidylcholine (LPC) 16:0, and LPC 18:0. The feasibility of MALDI-TOF MS based on the parylene-matrix chip was confirmed via analysis of spot-to-spot and shot-to-shot reproducibility. Serum metabolite markers of IHCC, N-methyl-2-pyridone-5-carboxamide (2PY), and glutamine were quantified using MALDI-TOF MS based on the parylene-matrix chip. For clinical diagnosis of CRC, two water-insoluble (barely soluble) biomarkers, lysophosphatidylcholine (LPC) 16:0 and LPC 18:0, were quantified. Finally, glutamine and LPC 16:0 were simultaneously detected at a range of concentrations in sera from colon cancer patients using the parylene-matrix chip. Thus, this method yielded high-throughput detection of cancer biomarkers for the mixture samples of water-soluble analytes (2PY and glutamine) and water-insoluble analytes (LPC 16:0 and LPC 18:0).
|Number of pages||10|
|Journal||Journal of the American Society for Mass Spectrometry|
|Publication status||Published - 2020 Apr 1|
Bibliographical noteFunding Information:
This study was supported by the Ministry of Trade, Industry and Energy (MOTIE, Korea); the Industry Technology Development Program (Grant 10063335) funded by the Ministry of Trade, Industry and Energy (MOTIE, Korea); and the National Research Foundation of Korea (Grants NRF-2020R1A2B5B01002187).
© 2021 American Society for Mass Spectrometry. Published by the American Chemical Society. All rights reserved.
All Science Journal Classification (ASJC) codes
- Structural Biology